The Food and Drug Administration (FDA) is now saying that it will take 75 years, rather than their initial estimate of 55 years, to produce clinical data to the public on Pfizer’s COVID-19 vaccine.
The FDA is telling a court of law that they discovered 59,000 more pages of the clinical data that it will have to produce to the public. They now claim they can analyze more than 500 pages per month, but the additional pages will add two decades to the initial estimate of time it will take to produce the documents.
“If you find what you are reading difficult to believe—that is because it is dystopian for the government to give Pfizer billions, mandate Americans to take its product, prohibit Americans from suing for harms, but yet refuse to let Americans see the data underlying its licensure,” said Aaron Siri, an attorney who is working on the case.
The Public Health and Medical Professionals for Transparency brought on the case, demanding that the FDA provide the information to the public in a timely manner. This group includes Peter Doshi, an associate professor at the University of Maryland School of Pharmacy; Dr. Carole Browner, a research professor at the University of California–Los Angeles’s David Geffen School of Medicine; and Dr. Harvey Risch, a professor of epidemiology at the Yale School of Public Health.
